Browsing by Author "Caro Vega, Yanink"

Now showing items 1-6 of 6

    • CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected ... 
      Luz, Paula M.; Belaunzarán Zamudio, Pablo; Crabtree Ramírez, Brenda; Caro Vega, Yanink; Hoces, Daniel; Rebeiro, Peter F.; Blevins, Meridith; Pape, Jean W.; Cortés Moncada, Claudia; Padgett, Denis; Cahn, Pedro; Veloso, Valdilea G.; McGowan, Catherine C.; Grinsztejn, Beatriz; Shepherd, Bryan E. (Oxford University Press, 2015)
      We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virusinfected adults from Latin America and the Caribbean. ...
    • Cross-sectional analysis of late HARRT initiation in Latin America and the Caribbean: Late testers and late ... 
      Crabtree Ramírez, Brenda; Caro Vega, Yanink; Shepherd, Bryan E.; Wehbe, Firas; Cesar, Carina; Cortés, Claudia; Padgett, Denis; Koenig, Serena; Gotuzzo, Eduardo; Cahn, Pedro; McGowan, Catherine C.; Masys, Daniel; Sierra Madero, Juan Juan; The CCASAnet Team, (2011)
      Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initiation in HIV-infected subjects in developing countries. Data from Latin America and the Caribbean is still ...
    • Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and ... 
      Núñez, Isaac; Crabtree Ramirez, Brenda; Shepherd, Bryan E.; Sterling, Timothy R.; Cahn, Pedro; Veloso, Valdiléa G.; Cortés Moncada, Claudia Paz; Padgett, Denis; Gotuzzo, Eduardo; Sierra Madero, Juan; McGowan, Catherine C.; Person, Anna K.; Caro Vega, Yanink (Elsevier, 2022)
      Objectives: The aim of this study was to describe the incidence, clinical characteristics, and risk factors of late-onset opportunistic infections (LOI) in people who live with HIV (PWLHA) within the Caribbean, Central and ...
    • Monitoring of HIV treatment in seven countries in the WHO Region of the Americas 
      Belaunzarán Zamudio, Pablo; Caro Vega, Yanink; Shepherd, Bryan; Crabtree Ramírez, Brenda; Luz, Paula; Grinsztejn, Beatriz; Cesar, Carina; Cahn, Pedro; Cortés, Claudia; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo, Eduardo; McGowan, Catherine; Sierra Madero, Juan (World Health Organization, 2015)
      Objective To determine the prevalence of adequate monitoring and the costs of measuring CD4+T-Iymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral load in people receiving antiretroviral therapy (ART) in ...
    • Monitoring of HIV treatment in seven countries in the WHO region of the Americas Suivi du traitement du VIH ... 
      Belaunzarán Zamudio, Pablo; Caro Vega, Yanink; Shepherd, Bryan E.; Crabtree Ramírez, Brenda; Luz, Paula M.; Grinsztejn, Beatriz; Cesar, Carina; Cahn, Pedro; Cortés, Claudia; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo, Eduardo; McGowan, Catherine (World Health Organization, 2015)
      © 2015, World Health Organization. All Rights Reserved. Objective To determine the prevalence of adequate monitoring and the costs of measuring CD4+ T-lymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral ...
    • Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS ... 
      Crabtree Ramírez, Brenda; Caro Vega, Yanink; Shepherd, Bryan E.; Grinsztejn, V; Grinsztejn, Beatriz; Wolff Reyes, Marcelo; Cortés Moncada, Claudia; Padgett, Denis; Carriquiry, Gabriela; Fink, Valeria; Jayathilake, Karu; Person, Anna K.; McGowan, Catherine; Sierra Madero, Juan (Public Library Science, 2016)
      Background Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in ...